These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 15922437)
1. Secondary transitional cell carcinoma and nitrogen mustard treatment. DeLair SM; White RW; Kurzrock EA Urology; 2005 Jun; 65(6):1226-7. PubMed ID: 15922437 [TBL] [Abstract][Full Text] [Related]
2. [Transitional cell carcinoma of the ureter and cyclophosphamide: apropos of a case]. Ponsot Y; Guerin JG; Carmel M Prog Urol; 1995 Sep; 5(4):578-9. PubMed ID: 7581511 [TBL] [Abstract][Full Text] [Related]
3. [Urinary bladder carcinoma was induced in a patient treated with cyclophosphamide for malignant lymphoma]. Yoshimoto K; Hisamochi A; Ogata H; Ide T; Nohno R; Fujita M; Kuboyama S; Sasaki E; Toyonaga A; Tanikawa K Rinsho Ketsueki; 1994 Mar; 35(3):300-3. PubMed ID: 8158853 [TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the renal pelvis in a patient with cyclophosphamide therapy for malignant lymphoma: a case report and literature review. Shiga Y; Suzuki K; Tsutsumi M; Ishikawa S Hinyokika Kiyo; 2002 May; 48(5):301-5. PubMed ID: 12094715 [TBL] [Abstract][Full Text] [Related]
5. [Cyclophosphamide-induced bladder cancer: three case reports]. Kijima T; Masuda H; Suzuki M; Okada Y; Yano M; Hyochi N; Fujii Y; Kawakami S; Hayashi T; Kobayashi T; Kihara K Hinyokika Kiyo; 2003 Aug; 49(8):483-6. PubMed ID: 14518387 [TBL] [Abstract][Full Text] [Related]
6. Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report. Nakamoto T; Kasaoka Y; Ikegami Y; Usui T Hiroshima J Med Sci; 2000 Jun; 49(2):121-3. PubMed ID: 10920579 [TBL] [Abstract][Full Text] [Related]
7. [Cyclophosphamide induced urinary bladder and renal pelvic tumor--a case report]. Inagaki T; Ebisuno S Nihon Hinyokika Gakkai Zasshi; 1998 Jul; 89(7):674-7. PubMed ID: 9739590 [TBL] [Abstract][Full Text] [Related]
8. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802 [TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. Pedersen-Bjergaard J; Ersbøll J; Hansen VL; Sørensen BL; Christoffersen K; Hou-Jensen K; Nissen NI; Knudsen JB; Hansen MM N Engl J Med; 1988 Apr; 318(16):1028-32. PubMed ID: 3352696 [TBL] [Abstract][Full Text] [Related]
10. Bladder cancer after chemotherapy for non-Hodgkin's lymphoma. Travis LB; Curtis RE; Boice JD; Fraumeni JF N Engl J Med; 1989 Aug; 321(8):544-5. PubMed ID: 2761594 [No Abstract] [Full Text] [Related]
11. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma. Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M; Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834 [TBL] [Abstract][Full Text] [Related]
12. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study. Lindahl LM; Fenger-Grøn M; Iversen L Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659 [TBL] [Abstract][Full Text] [Related]
13. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496 [TBL] [Abstract][Full Text] [Related]
14. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte. van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ; J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571 [TBL] [Abstract][Full Text] [Related]
17. Topical treatment of early cutaneous T-cell lymphoma. Ramsay DL; Meller JA; Zackheim HS Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483 [TBL] [Abstract][Full Text] [Related]
18. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107 [TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419 [TBL] [Abstract][Full Text] [Related]
20. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]